Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Using Twitter to probe political polarization

  • Wobbly no more: Work on analogical processing helps children learn key engineering principle

  • How are ordinary consumers transforming the fashion business?

  • When are consumers more likely to rely on feelings to make decisions?

  • Saving money: Do consumers spend less if they think about the future?

  • Cultivating timeflow: Can consumers shape how they experience time?

  • Scientists one step closer to finding how to repair damaged nerve cells

  • Chronic loneliness in older adults leads to more doctors' office visits, study finds

  • Do consumers think products are better when companies donate to charity?

  • A matter of taste: When do products benefit from mixed reviews?

  •